General Information of Drug (ID: DM6URNJ)

Drug Name
JNJ-67856633 Drug Info
Indication
Disease Entry ICD 11 Status REF
Chronic lymphocytic leukaemia 2A82.0 Phase 1 [1]
Non-hodgkin lymphoma 2B33.5 Phase 1 [1]
Cross-matching ID
PubChem CID
134609793
TTD Drug ID
DM6URNJ

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
MALT lymphoma-associated translocation (MALT1) TTCI81G MALT1_HUMAN Inhibitor [2]

References

1 ClinicalTrials.gov (NCT03900598) A Study of JNJ-67856633 in Participants With Non-Hodgkin's Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL). U.S. National Institutes of Health.
2 National Cancer Institute Drug Dictionary (drug name JNJ67856633).